XLO
Xilio Therapeutics Inc

1,675
Mkt Cap
$44.05M
Volume
1.05M
52W High
$1.70
52W Low
$0.615
PE Ratio
-1.11
XLO Fundamentals
Price
$0.8018
Prev Close
$0.8499
Open
$0.85
50D MA
$0.7697
Beta
0.68
Avg. Volume
580,505.22
EPS (Annual)
-$1.09
P/B
6.23
Rev/Employee
$99,125.00
Loading...
Loading...
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
64

Frequently Asked Questions

What is Market Cap of Xilio Therapeutics Inc?
What is the 52-week high for Xilio Therapeutics Inc?
What is the 52-week low for Xilio Therapeutics Inc?
What is Xilio Therapeutics Inc stock price today?
What was Xilio Therapeutics Inc stock price yesterday?
What is the PE ratio of Xilio Therapeutics Inc?
What is the Price-to-Book ratio of Xilio Therapeutics Inc?
What is the 50-day moving average of Xilio Therapeutics Inc?
How many employess does Xilio Therapeutics Inc has?

Latest XLO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.